NPPA to monitor the Prices
The National Pharmaceutical Pricing Authority (NPPA) has asked manufacturers of Oximeters and Oxygen Concentrators to submit price details of the two products. The NPPA that regulates the prices of pharmaceutical products and medical devices is monitoring the prices of these two devices under the Drug Price Control Order (DPCO).
The DPCO is the base document for pharma and devices pricing.
Apart from asking manufacturers to submit pricing details of these devices, the NPPA has asked them to not violate the price increase mechanism.
This notice is in reference to the Gazette Notification dated March 31, 2020 issued by NPPA for regulation of medical devices under DPCO-2013 read with Essential Commodities (EC) Act, 1955 with effect from April 1, 2020. Accordingly, MRP of medical devices cannot be increased more than ten per cent (10%) in a year.
In view of the above, all manufacturers or importers of aforesaid medical devices are hereby advised to ensure compliance of the provisions of Para 20 of the DPCO, 2013 failing which action may be initiated for violation of provisions of DPCO, 2013 read with EC Act, 1955.
“Medical devices industry associations of Pulse Oximeter and Oxygen Concentrator namely MTaI, AiMeD, CII, FICCI, USIBC, AMCHAM, AdvaMed are hereby directed to disseminate this office memorandum among its member companies and shall ensure compliance of the same.
Download the notification from NPPA here :